Alzheimer's Therapeutic Area User Guide v1.0

Published Date:

Version 1.0 of the Alzheimer's Disease Therapeutic Area User Guide (TAUG-Alzheimer's) was developed in collaboration between CDISC and the Coalition Against Major Diseases (CAMD) - a program of the Critical Path Institute. TAUG-Alzheimer's v1.0 describes how to implement SDTM safety domains related to Alzheimer's disease (AD)/Mild Cognitive Impairment (MCI) clinical trials.

Public Review Comments

CDISC posts Public Review comments and resolutions to ensure transparency and show implementers how comments were addressed in the standard development process.